Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

31826
1
Celldex Therapeutics, Inc. Celldex Therapeutics Reports 110% Revenue Growth, Operating Losses Widen in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31827
1
FIRST BANCORP /NC/ First Bancorp Reports Strong Cash and Deposit Growth, Net Income Decline in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31828
1
Precipio, Inc. Precipio Reports 15% Revenue Growth, Net Loss Reduction in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31829
1
TRANSCAT INC Transcat, Inc. Reports 8% Revenue Growth, Strong Net Income in Q2 and First Half of Fiscal Year 2025

Via official filing (AI summary) | over 1 year ago | 0 comments

31830
1
8X8 INC /DE/ 8x8 Reports Decline in Revenue, Increase in Operating Expenses, and Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31831
1
Merck & Co., Inc. Merck Reports 4% Sales Growth, Mixed Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31832
1
Wenyuan Group Corp. Wenyuan Group Reports Significant Revenue Growth and Improved Financial Performance in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31833
1
Quantum Computing Inc. Quantum Computing Inc. Reports 102% Revenue Growth, Improved Losses, and Enhanced Working Capital in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31834
1
ProFrac Holding Corp. ProFrac Holding Corp. Reports Mixed Q3 Results Amid Challenging Market Conditions

Via official filing (AI summary) | over 1 year ago | 0 comments

31835
1
Playa Hotels & Resorts N.V. Playa Hotels & Resorts Reports Decline in Revenue, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31836
1
TripAdvisor, Inc. TripAdvisor Reports Mixed Q3 Results, Revenue Growth in First Nine Months of 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31837
1
TIGO ENERGY, INC. Tigo Energy Reports Significant Financial Challenges, Decline in Revenue and Net Income

Via official filing (AI summary) | over 1 year ago | 0 comments

31838
1
GLADSTONE LAND Corp Gladstone Land Corporation Reports Mixed Financial Results for Q3 2024, Focuses on Strategic Asset Management

Via official filing (AI summary) | over 1 year ago | 0 comments

31839
1
WW INTERNATIONAL, INC. WW International Reports Significant Financial Challenges, Decline in Revenues and Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

31840
1
TerrAscend Corp. TerrAscend Corp. Reports 17% Decline in Quarterly Revenue, Net Losses Increase

Via official filing (AI summary) | over 1 year ago | 0 comments

31841
1
Adicet Bio, Inc. Adicet Bio Reports Financial Results, Net Loss Decrease, and Shift in Focus to ADI-001 for Autoimmune Diseases

Via official filing (AI summary) | over 1 year ago | 0 comments

31842
1
Net Lease Office Properties Net Lease Office Properties Reports Significant Financial Changes in 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments

31843
1
MEDALLION FINANCIAL CORP Medallion Financial Reports Q3 2024 Results: Asset Growth, Net Interest Income Increase, but Profitability Declines

Via official filing (AI summary) | over 1 year ago | 0 comments

31844
1
AMICUS THERAPEUTICS, INC. Amicus Therapeutics Reports Strong Financial Growth, Net Product Sales Reach $141.5M in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31845
1
Arbutus Biopharma Corp Arbutus Biopharma Reports Mixed Financial Results for Q3 2024, Net Loss Widens

Via official filing (AI summary) | over 1 year ago | 0 comments

31846
1
Context Therapeutics Inc. Context Therapeutics Reports Significant Financial Developments, Cash and Cash Equivalents Rise to $84.8 Million

Via official filing (AI summary) | over 1 year ago | 0 comments

31847
1
Solid Biosciences Inc. Solid Biosciences Reports Financial Results for Q3 2024, Completes Private Placement and Advances Gene Therapy Pipeline

Via official filing (AI summary) | over 1 year ago | 0 comments

31848
1
MONOLITHIC POWER SYSTEMS INC Monolithic Power Systems Reports 30.6% Revenue Growth in Q3 2024, Driven by Strong Enterprise Data Market Performance

Via official filing (AI summary) | over 1 year ago | 0 comments

31849
1
Pacira BioSciences, Inc. Pacira BioSciences Reports Revenue Growth, Increased Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31850
1
Sarepta Therapeutics, Inc. Sarepta Therapeutics Reports 41% Revenue Growth in Q3 2024, Net Income Turnaround

Via official filing (AI summary) | over 1 year ago | 0 comments